Why Is TEMPUS AI INC A (TEM) Stock Up Today?

Why TEM stock is up today

Tempus AI Inc Class A stock surged 10.13% to $67.45 in the current session. The rally follows a price target increase from BTIG and broader market enthusiasm over recent developments in the cancer vaccine space involving Moderna and Merck. The stock is trading near its 52-week high amid strong intraday momentum and unusual call option activity.

What Happened

BTIG raised its price target for Tempus AI from $70 to $80, reinforcing a positive outlook for the stock. This move came as investors reacted to a late-stage clinical trial success by Merck and Moderna in the cancer vaccine space, which has drawn comparisons to Tempus AI's recent $1.5 billion acquisition of Personalis. The acquisition, announced last month, is now seen as a strategic validation by the market, with Tempus's unique business model and technological capabilities drawing renewed attention.

The stock opened slightly lower than the previous close but quickly reversed direction to reach a session high of $67.51. The session has been marked by directional bullishness, with call volume exceeding normal levels. The stock's volatility is reflected in its beta of 3.58, and the rally has added to a year-to-date revenue growth of 50.4%.

What The Data Shows

The stock has traded between $40.77 and $104.32 over the past 52 weeks, and it is currently trading near the upper end of that range. Unusual options activity has been heavily skewed to the call side, with $26 million in call premiums compared to just $44,000 in put premiums. The largest single options print was $6.3 million. Additionally, the stock has printed 15 fresh 52-week highs on August 20. Insiders have sold a total of $33.4 million in the last 90 days, while only one insider has made a purchase.

What To Watch

The stock is currently trading near its 52-week high and has shown strong momentum. Investors may want to monitor the coverage breadth as the stock continues to attract attention from analysts and traders.